NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

Aspira Pathlab & Diagnostics L

BSE: 540788 22 Feb 2025
Healthcare
₹ 65.9
Aspira Pathlab & Diagnostics Limited specializes in Healthcare Service Provider within the Healthcare sector.

Aspira Pathlab & Diagnostics L - Share Price & Details

Market Cap
₹67.8
High /Low
83.9 / 25.0
Stock P/E
79.8
Book Value
₹10.8
Dividend Yield
0.0
ROCE
-15.9
ROE
₹-41.0
Face Value
10.0
PEG Ratio
9.71
EVEBITDA
₹25.4
Debt
2.48
CMP / FCF
98.8
Debt to equity
₹0.22
NP Ann
-2.67
High price all time
124.0
Piotroski score
₹4.0
Graham Number
14.2
No. Eq. Shares
1.03
Net CF
₹0.24
Net profit
0.85
Price to book value
6.1
Interest Coverage
₹3.52
Low price all time
14.2
Industry PE
54.7
Reserves
₹0.82
Free Cash Flow
₹0.79

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
Aspira Pathlab & Diagnostics L54.070.3079.8
GODAVARI DRUGS LTD.295.521.0210.7
VIVO BIO TECH LTD.120.353.569.33

Peer Comparison Chart


About Aspira Pathlab & Diagnostics L

Aspira Pathlab & Diagnostics Limited, with Security Code 540788, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Shares Below Rs 100: Only Buyers Were Seen In These Stocks, Locked in Upper Circuit Today

(10 Jan 2025)
The broader markets were in the red territory, with the BSE Mid-cap Index down 2.13 per cent and the BSE Small-cap Index down 2.40 per cent.
Read more →

Diagnostic stocks surge amid HMPV scare

(09 Jan 2025)
Shares of seven diagnostics companies surged 0.8% to 12.27% following reports of an HMPV (Human Metapneumovirus) outbreak in China and the...
Read more →

CAG report reveals majority of blood banks in Bihar operate without licenses

(17 Dec 2024)
A Comptroller and Auditor General of India report on Bihar's healthcare sector has found acute shortage of doctors and paramedical staff and...
Read more →

Aspira Pathlab & Diagnostics Reaches New 52-Week High, Outperforms Sector and Sensex

(02 Dec 2024)
Aspira Pathlab & Diagnostics, a microcap company in the hospital and healthcare services industry, has recently reached a new 52-week high...
Read more →

Suraksha Diagnostic IPO received 11% subscription on first day

(30 Nov 2024)
The initial public offer of Suraksha Diagnostic Ltd got subscribed 11 per cent on the first day of share sale on Friday.
Read more →

Aspira Pathlab & Diagnostics Surges to 52-Week High, Outperforms Sensex in Healthcare Industry

(30 Nov 2024)
Aspira Pathlab & Diagnostics, a microcap company in the hospital and healthcare services industry, has recently seen a surge in its stock...
Read more →